insulin glargine vs pramlintide
Side-by-side comparison of insulin glargine and pramlintide. Data from FDA drug databases (Orange Book, NDC Directory, recalls, shortages) covering 20,000+ approved drugs, plus CMS pricing; see our methodology.
moderate Known Drug Interaction
7 DRUG INTERACTIONS Table 6 includes clinically significant drug interactions with BASAGLAR Table 6: Clinically Significant Drug Interactions with BASAGLAR Drugs That May Increase the Risk of Hypoglycemia Drugs: Antidiabetic agents, ACE inhibitors, angiotensin II receptor blocking agents, disopyramide, fibrates, fluoxetine, monoamine oxidase inhibitors, pentoxifylline, pramlintide, salicylates, somatostatin analogs (e.g., octreotide), and sulfonamide antibiotics. Drugs that may increase the risk of hypoglycemia: antidiabetic agents, ACE inhibitors, angiotensin II receptor blocking agents,...
Recommendation: Your healthcare provider may need to adjust your insulin dose and you should monitor your blood sugar levels frequently.
Lantus, Basaglar, Toujeo
Symlin
Basaglar is a long-acting insulin that helps control blood sugar levels. It is used to treat type 1 and type 2 diabetes.
Symlin is a drug that helps control blood sugar in people with type 1 or type 2 diabetes who also use insulin. It works with insulin to lower blood sugar levels after meals.
Basaglar is used to lower blood sugar in adults and children with type 1 diabetes. It also helps adults with type 2 diabetes manage their blood sugar. However, Basaglar is not for treating diabetic ketoacidosis, a serious condition with high levels of ketones in the blood.
Symlin is used to help manage blood sugar levels in adults with type 1 or type 2 diabetes. You should already be using insulin at mealtimes. This medicine is for people whose blood sugar is not well-controlled, even with the best insulin treatment.
Basaglar is a long-acting form of insulin. It works by replacing the insulin that your body does not make, or helping your body use insulin better. This helps to lower your blood sugar levels over a longer period.
Symlin is similar to a natural hormone in your body. It slows down how quickly food leaves your stomach. It also helps to prevent your liver from releasing too much sugar after you eat, and reduces your appetite.
- • Low blood sugar (hypoglycemia)
- • Allergic reactions
- • Injection site reactions (redness, swelling, itching)
- • Skin thickening or pits at the injection site
- • Itching
- • Nausea
- • Vomiting
- • Loss of appetite
- • Headache
- • Fatigue
- Increased blood sugar 38,213
- Decreased blood sugar 10,314
- Taking the medicine at the wrong time 9,798
- Feeling sick to your stomach 9,566
- The medicine was stored incorrectly 8,531
- High blood sugar 15
- Sudden kidney damage 11
- Long-term kidney disease 11
- Feeling sick to your stomach 9
- Shortness of breath 8
Never share your Basaglar pen with anyone else, even if you change the needle. Sharing pens can spread blood-borne diseases. Changes to your insulin plan can affect your blood sugar. Make sure a doctor supervises any changes and that you check your blood sugar often. Low blood sugar can be very dangerous and even life-threatening. Watch for symptoms and check your blood sugar often. Low potassium can also be life-threatening. Tell your doctor if you have heart problems or take certain diabetes medicines called thiazolidinediones, as this can lead to heart failure.
Symlin can cause very low blood sugar, especially if you have type 1 diabetes. This can happen within 3 hours after a Symlin shot. To avoid this, follow your doctor's instructions carefully and check your blood sugar often. Make sure you know the signs of low blood sugar.
Talk to your doctor if you are pregnant or plan to become pregnant. Poorly controlled diabetes during pregnancy can harm both the mother and the baby. Basaglar's effects during pregnancy are not well-studied.
It is not known if Symlin will harm your unborn baby. Talk to your doctor if you are pregnant or plan to become pregnant. It is also not known if Symlin passes into breast milk, so discuss breastfeeding with your doctor.
Also Compare, Nearby Drugs
Compare insulin glargine with
How to Read This insulin glargine vs pramlintide Comparison
insulin glargine is classified in the Long-Acting Insulin drug class, while pramlintide sits within the Amylin Analog class. Drugs from different classes work through distinct mechanisms, so a head-to-head comparison illustrates trade-offs rather than equivalence. Both drugs are prescription-only, so a licensed provider must authorize use.
Adverse event totals above are pulled from the FDA's Adverse Event Reporting System (FAERS). For these top-ranked reactions alone, insulin glargine has 76,422 submissions while pramlintide has 54. Those figures reflect cumulative reporting volume, not per-patient risk, so older, widely dispensed drugs typically look worse on count alone. These two drugs have a known moderate interaction flagged in FDA labeling, attributed to both medications are used to lower blood sugar, so using them at the same time increases the risk of hypoglycemia.. Serious warnings, pregnancy guidance, and contraindications can differ even when indications overlap.
A table cannot substitute for clinical judgment. Effectiveness, tolerability, drug-drug interactions with your other medications, kidney and liver function, pregnancy status, insurance formulary, and price all feed into a decision that only a licensed prescriber can make responsibly. Data here is sourced from FDA Structured Product Labels (SPL) and FAERS, both of which update as manufacturers and clinicians submit new information. This page is for educational purposes only, is not medical advice, and should not be used to self-switch between insulin glargine and pramlintide - always consult your physician or pharmacist first.
Important: This comparison is for informational purposes only. Drug effects vary between individuals. Always consult your doctor or pharmacist for personalized medical advice.